Last update: June 10, 2018
Minimal risk for breastfeeding and infant.
An imidazole antifungal agent used topically as a skin cream or in the form of vaginal ovules.
Since the last update date we have not found published data on its excretion in breastmilk.
The mean plasma concentration after the application of 300 mg of vaginal sertaconazole was 1.79 ± 0.70 micrograms/L (Wang 2009).
Its insignificant or zero systemic absorption through vaginal mucosa or skin (Croxtall 2009, Wang 2009, Susilo 2006, Farré 1992) and its high plasma protein binding makes transfer to milk in significant quantities unlikely.
You should wash your hands well after application.
Do not apply on breast-nipple-areola or clean before breastfeeding.
We do not have alternatives for D01AC14 since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2006 from United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM